Emerging Concepts in the Management and Treatment of Osteonecrosis of the Jaw

Publication Date

2013

Journal Title

Oral Maxillofac Surg Clin North Am

Abstract

Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2004, there have been multiple retrospective, prospective, and case-control studies that have served to characterize the diagnosis, associated risk factors, and treatment of this new complication. Bisphosphonate-related osteonecrosis of the jaw is at present associated with several risk factors that are identified across several disciplines in medicine and dentistry. With this level of broad-based recognition, new clinical and basic science research initiatives have begun and are likely to elucidate the etiopathogenesis of this disease process, significantly improving the level of disease management and prevention. © 2013 Elsevier Inc.

Volume Number

25

Issue Number

1

Pages

11 - 20

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Dental Medicine

PMID

23159218

DOI

10.1016/j.coms.2012.10.002

For the public and Northwell Health campuses

Share

COinS